Third Pfizer vax dose more effective in reducing severe Covid: Lancet
A third vaccine dose of Pfizer-BioNTech is effective in reducing severe Covid related outcomes compared to individuals who have received two vaccine doses at least five months ago, finds a new study.
A third vaccine dose of Pfizer-BioNTech is effective in reducing severe Covid related outcomes compared to individuals who have received two vaccine doses at least five months ago, finds a new study. https://ift.tt/2ZIai0w October 31, 2021 at 12:59AM
A third vaccine dose of Pfizer-BioNTech is effective in reducing severe Covid related outcomes compared to individuals who have received two vaccine doses at least five months ago, finds a new study. https://ift.tt/2ZIai0w October 31, 2021 at 12:59AM
Comments
Post a Comment